MCID: ART084
MIFTS: 48

Arteriovenous Fistula

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Arteriovenous Fistula

MalaCards integrated aliases for Arteriovenous Fistula:

Name: Arteriovenous Fistula 38 55

Classifications:



Summaries for Arteriovenous Fistula

MalaCards based summary : Arteriovenous Fistula is related to arteriovenous malformation and end stage renal failure. An important gene associated with Arteriovenous Fistula is EPO (Erythropoietin), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Pathways in cancer. The drugs Dexmedetomidine and Propofol have been mentioned in the context of this disorder. Affiliated tissues include kidney, endothelial and heart, and related phenotypes are cardiovascular system and immune system

Wikipedia : 76 An arteriovenous fistula is an abnormal connection or passageway between an artery and a vein. It may be... more...

Related Diseases for Arteriovenous Fistula

Diseases in the Arteriovenous Fistula family:

Congenital Systemic Arteriovenous Fistula

Diseases related to Arteriovenous Fistula via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 337)
# Related Disease Score Top Affiliating Genes
1 arteriovenous malformation 31.4 IL6 RASA1
2 end stage renal failure 30.3 EPO IL6
3 ischemic colitis 30.2 APOH MMP2
4 endocarditis 30.1 APOH IL6
5 arteriovenous malformations of the brain 30.0 IL6 RASA1
6 myelitis 30.0 APOH IL6
7 polyarteritis nodosa 29.7 APOH IL6
8 kidney disease 29.7 EPO HMOX1 IL6
9 aortic aneurysm, familial abdominal, 1 29.7 IL6 MMP2
10 vascular disease 29.6 APOH HMOX1 IL6
11 transverse myelitis 29.6 APOH IL6 MMP2
12 retinal artery occlusion 29.5 APOH IL6
13 infective endocarditis 29.5 APOH IL6
14 intermittent claudication 29.5 APOH IL6
15 brain edema 29.5 HMOX1 IL6
16 temporal arteritis 29.5 APOH IL6
17 hepatocellular carcinoma 29.1 EPO HMOX1 IL6 MMP2
18 pulmonary arteriovenous fistulas 12.4
19 congenital systemic arteriovenous fistula 12.4
20 angiokeratoma corporis diffusum with arteriovenous fistulas 12.3
21 pulmonary arterio-veinous fistula 12.1
22 parkes weber syndrome 11.8
23 klippel-trenaunay-weber syndrome 11.6
24 dural sinus malformation 11.6
25 pulmonary arteriovenous malformation 11.5
26 capillary malformation-arteriovenous malformation 11.5
27 telangiectasia, hereditary hemorrhagic, type 4 11.4
28 thrombosis 10.6
29 hereditary hemorrhagic telangiectasia 10.4
30 weber syndrome 10.3
31 portal hypertension 10.3
32 pulmonary hypertension 10.3
33 dementia 10.3
34 paraplegia 10.3
35 coronary artery aneurysm 10.3
36 angiosarcoma 10.2
37 fibromuscular dysplasia 10.2
38 trigeminal neuralgia 10.2
39 telangiectasis 10.2
40 ischemia 10.2
41 intracranial hypertension 10.2
42 angioosteohypertrophic syndrome 10.2
43 neurofibromatosis, type i 10.1
44 exophthalmos 10.1
45 actinic keratosis 10.1 MMP2 PCNA
46 thrombophilia due to thrombin defect 10.1
47 chronic kidney failure 10.1
48 subclavian steal syndrome 10.1
49 thrombophlebitis 10.1
50 ameloblastoma 10.1 MMP2 PCNA

Graphical network of the top 20 diseases related to Arteriovenous Fistula:



Diseases related to Arteriovenous Fistula

Symptoms & Phenotypes for Arteriovenous Fistula

MGI Mouse Phenotypes related to Arteriovenous Fistula:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.65 EPO HMOX1 IL6 MMP2 RASA1
2 immune system MP:0005387 9.63 EPO HMOX1 IL6 MMP2 PCNA RASA1
3 mortality/aging MP:0010768 9.5 APOH EPO HMOX1 IL6 MMP2 PCNA
4 muscle MP:0005369 9.02 EPO HMOX1 IL6 MMP2 RASA1

Drugs & Therapeutics for Arteriovenous Fistula

Drugs for Arteriovenous Fistula (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 196)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
2
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
3
Nitric Oxide Approved Phase 4,Not Applicable 10102-43-9 145068
4
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 137-58-6 3676
5
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
6
Ezetimibe Approved Phase 4 163222-33-1 150311
7
Simvastatin Approved Phase 4 79902-63-9 54454
8 tannic acid Approved Phase 4,Not Applicable
9
Benzocaine Approved, Investigational Phase 4,Not Applicable 94-09-7, 1994-09-7 2337
10
Clopidogrel Approved Phase 4,Phase 3 113665-84-2, 120202-66-6 60606
11
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
12
Heparin Approved, Investigational Phase 4,Phase 2,Not Applicable 9005-49-6 772 46507594
13
Bivalirudin Approved, Investigational Phase 4 128270-60-0 16129704
14
Amiodarone Approved, Investigational Phase 4 1951-25-3 2157
15
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3 1197-18-8 5526
16
Nitroglycerin Approved, Investigational Phase 4,Not Applicable 55-63-0 4510
17
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 10909430 439542
18
Fondaparinux Approved, Investigational Phase 4 104993-28-4
19
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 175805 71273
20
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
21
Iron Approved Phase 4 7439-89-6 23925
22
Tetracaine Approved, Vet_approved Phase 4 94-24-6 5411
23
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
24
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
25
Ergocalciferol Approved, Nutraceutical Phase 4,Not Applicable 50-14-6 5280793
26
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 1406-16-2
27 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Not Applicable
28 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Not Applicable
29 Adrenergic Agonists Phase 4,Not Applicable
30 Adrenergic alpha-2 Receptor Agonists Phase 4
31 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
32 Anesthetics Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
33 Anesthetics, Intravenous Phase 4
34 Adrenergic alpha-Agonists Phase 4,Not Applicable
35 Adrenergic Agents Phase 4,Not Applicable
36 Analgesics Phase 4,Not Applicable
37 Anesthetics, General Phase 4
38 Analgesics, Non-Narcotic Phase 4,Not Applicable
39 Hypnotics and Sedatives Phase 4
40 Anesthetics, Local Phase 4,Phase 2,Phase 3,Not Applicable
41 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Not Applicable
42 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 2,Not Applicable
43 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Not Applicable
44 Atorvastatin Calcium Phase 4,Phase 1,Phase 2 134523-03-8
45 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4,Phase 2,Phase 1
46 Hematinics Phase 4
47 Parenteral Nutrition Solutions Phase 4
48 Pharmaceutical Solutions Phase 4,Phase 2,Not Applicable,Early Phase 1
49 Ferrosoferric Oxide Phase 4
50 Purinergic P2 Receptor Antagonists Phase 4,Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 278)
# Name Status NCT ID Phase Drugs
1 Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery Unknown status NCT02447796 Phase 4 Propofol;Dexmedetomidine
2 Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients Unknown status NCT01138254 Phase 4
3 2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula Unknown status NCT00993746 Phase 4 Bupivacaine plus lidocaine;Bupivacaine 30 ml
4 Ultrasound Guided Cannulation of Dialysis Fistulas Unknown status NCT01163981 Phase 4
5 Vacuumtherapy After Venous Hybrid Procedures Unknown status NCT02905955 Phase 4
6 Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty Unknown status NCT00952770 Phase 4
7 Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease Unknown status NCT02997046 Phase 4
8 AF Ablation With or Without ROX Coupler Study Unknown status NCT02243891 Phase 4
9 Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy Unknown status NCT01572129 Phase 4 Clopidogrel;Placebo
10 Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Unknown status NCT00476944 Phase 4
11 Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting Unknown status NCT01572623 Phase 4 Clopidogrel;Atorvastatin
12 AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation Unknown status NCT02341105 Phase 4 Amiodarone
13 Effects of Heparin on Arteriovenous Fistula Patency Completed NCT02493504 Phase 4 Heparin
14 The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas Completed NCT01685710 Phase 4 GTN patch;placebo comparator
15 Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Completed NCT00832611 Phase 4
16 Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients Completed NCT00544492 Phase 4
17 Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients Completed NCT02106962 Phase 4 Topical Tranexamic Acid 5% with bacitracin
18 Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis Completed NCT00737620 Phase 4
19 A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery Completed NCT01004627 Phase 4
20 AngioSeal Versus Radial Approach in Acute Coronary Syndrome Completed NCT01653587 Phase 4
21 Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Completed NCT03140631 Phase 4 Protamine Sulfate
22 Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial Completed NCT01389375 Phase 4
23 A Clinical Trial of IntensiVE Dialysis Completed NCT00649298 Phase 4
24 Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) Completed NCT00790907 Phase 4 fondaparinux background and standard dose UFH;Fondaparinux background and low dose heparin;Open label fondaparinux
25 The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery Recruiting NCT03311581 Phase 4 Propofol
26 Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention Recruiting NCT02831166 Phase 4
27 Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. Recruiting NCT03304496 Phase 4 Nitroglycerin 100 MCG/ML Injectable Solution;Saline Solution
28 Paricalcitol Improves Anemia of Inflammation Recruiting NCT02876211 Phase 4 Paricalcitol;Epoetin beta;Placebo
29 Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil Active, not recruiting NCT02729740 Phase 4
30 Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias Terminated NCT01623583 Phase 4
31 ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF Terminated NCT02056938 Phase 4 Anti-Thymocyte Globulins treatment;Basiliximab treatment
32 Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions Terminated NCT02028325 Phase 4 Fluorescein Sodium
33 Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. Terminated NCT00421252 Phase 4 clopidogrel 600 mg
34 Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze Unknown status NCT01854476 Phase 2, Phase 3
35 Efficacy Study of Assiut Femoral Compression Device Versus Manual Compression in the Achievement of Hemostasis Unknown status NCT02214030 Phase 3
36 First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) Unknown status NCT00392054 Phase 3 Conventional Antiarrhythmic Drug Therapy
37 Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Completed NCT01471041 Phase 2, Phase 3
38 Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae Completed NCT02440022 Phase 3
39 Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Completed NCT02363972 Phase 3
40 Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis Completed NCT03289520 Phase 3 Clopidogrel;Placebo
41 Duplex Guided Application of Local Anesthetic Before Femoral Artery Catheterization Completed NCT00903825 Phase 2, Phase 3
42 Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis Completed NCT01084148 Phase 3 V0034CR01B;V0034CR01B vehicle
43 RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial Completed NCT01446263 Phase 3
44 Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula Recruiting NCT02753998 Phase 3
45 Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Recruiting NCT03183245 Phase 3
46 Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Recruiting NCT02513303 Phase 3 Sirolimus
47 Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon Recruiting NCT02565953 Phase 3
48 A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) Active, not recruiting NCT02414841 Phase 3 vonapanitase;Placebo
49 A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) Active, not recruiting NCT02110901 Phase 3 PRT-201;Placebo
50 A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension Active, not recruiting NCT01642498 Phase 3

Search NIH Clinical Center for Arteriovenous Fistula

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Arteriovenous Fistula cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Arteriovenous Fistula:
VASCUGEL�, aortic endothelial cells for vascular injury and disease
Embryonic/Adult Cultured Cells Related to Arteriovenous Fistula:
Aortic endothelial cells cultured in matrix (VASCUGEL�) PMIDs: 7667257
Aortic endothelial cells cultured in matrix PMIDs: 7667257

Genetic Tests for Arteriovenous Fistula

Anatomical Context for Arteriovenous Fistula

MalaCards organs/tissues related to Arteriovenous Fistula:

41
Kidney, Endothelial, Heart, Liver, Brain, Spinal Cord, Skin

Publications for Arteriovenous Fistula

Articles related to Arteriovenous Fistula:

(show top 50) (show all 1358)
# Title Authors Year
1
Factors Associated with Secondary Functional Patency After Percutaneous Transluminal Angioplasty of the Early Failing or Immature Hemodialysis Arteriovenous Fistula. ( 30288592 )
2019
2
Development of a dural arteriovenous fistula subsequent to cerebral venous thrombosis by venous hypertension. ( 30555948 )
2019
3
A Review of the Current Status of Percutaneous Endovascular Arteriovenous Fistula Creation for Haemodialysis Access. ( 30030582 )
2019
4
Erratum Regarding "Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study" (Am J Kidney Dis. 2018;71[6]:793-801). ( 29960796 )
2018
5
Conus Medullaris Dural Arteriovenous Fistula Arising From the Artery of the Filum Terminale: 2-Dimensional Operative Video. ( 29444295 )
2018
6
Association of Preoperative Mean Arterial Pressure With the Primary Failure of Brescia-Cimino Arteriovenous Fistula Within the First 7 Days Following Surgery in Hemodialysis Patients. ( 29923672 )
2018
7
Giant arachnoid granulation with a thrombosed dural arteriovenous fistula. ( 29950364 )
2018
8
Omega-3 Polyunsaturated Fatty Acid Supplementation toA Prevent Arteriovenous Fistula and Graft Failure: AA Systematic Review and Meta-analysis of RandomizedA Controlled Trials. ( 29395485 )
2018
9
Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: AA NationalA Study. ( 29429750 )
2018
10
A rare cause of cyanosis in newborns: arteriovenous fistula between the right pulmonary artery and the left atrium and its treatment. ( 29362005 )
2018
11
Glucose pump test can be used to measure blood flow rate of native arteriovenous fistula in chronic hemodialysis. ( 29411718 )
2018
12
Successful Surgical Remodeling of a Giant Venous Aneurysm Formed in an Autogenous Arteriovenous Fistula: A Case Report. ( 29946222 )
2018
13
A Case of Dural Arteriovenous Fistula Mimicking a Cerebellar Tumor. ( 29977449 )
2018
14
Simultaneous transarterial and transvenous coil embolization for a large aneurysmal-type renal arteriovenous fistula. ( 29904500 )
2018
15
Paraplegia following lumbar puncture: a rare complication in spinal dural arteriovenous fistula. ( 29808310 )
2018
16
Regarding "A novel technique for duplex-guided office-based interventions for patients with acute arteriovenous fistula occlusion". ( 29937036 )
2018
17
Dural arteriovenous fistula between the inferolateral trunk and cavernous sinus draining to the ophthalmic vein: a case report. ( 29940382 )
2018
18
Prenatal diagnosis of isolated coronary arteriovenous fistula. ( 29372164 )
2018
19
Vertebral Arteriovenous Fistula: A Rare Complication Following Transpedicular Occipitocervical Fixation in a Patient with Atlantoaxial Dislocation. ( 29966140 )
2018
20
Spinal dural arteriovenous fistula: delay to radiological diagnosis and sources of radiological error. ( 29898828 )
2018
21
Pulmonary arteriovenous fistula complicated by venous thromboembolism and paradoxical cerebral infarction during early pregnancy. ( 29437680 )
2018
22
Choice of a second vascular access in hemodialysis patients whose initial arteriovenous fistula failed to mature. ( 29937290 )
2018
23
Unanticipated late maturation of an arteriovenous fistula after creation of separate graft access. ( 29928609 )
2018
24
Polymorphism in dural arteriovenous fistula: Matrix Metalloproteinase-2-1306 C/T as a potential risk factor for sinus thrombosis. ( 29431912 )
2018
25
Temporal evolution of a patient with a spinal dural arteriovenous fistula on serial MRI. ( 29423315 )
2018
26
Efficacy and comparison of elevation transposition and lipectomy for superficialization of cephalic arteriovenous fistula veins. ( 29926786 )
2018
27
Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula. ( 29624150 )
2018
28
Letter to the Editor. Steroid administration in Cognard type V dural arteriovenous fistula. ( 29393812 )
2018
29
Electrocardiographic artifact due to an arteriovenous fistula. ( 29933853 )
2018
30
Pial arteriovenous fistula of the spine in a child with hemiplegia. ( 29881582 )
2018
31
Reversible Cerebral Vasoconstriction Syndrome as an Unusual Complication of a Dural Arteriovenous Fistula treated with Onyx Embolization. ( 29751188 )
2018
32
Unique percutaneous direct puncture technique for occlusion of a hypoglossal canal dural arteriovenous fistula. ( 29909379 )
2018
33
Recurring thalamic symptoms due to intracranial dural arteriovenous fistula: a report of an unusual case and its treatment outcome. ( 29969738 )
2018
34
A systematic review and meta-analysis of one-stage versus two-stage brachiobasilic arteriovenous fistula creation. ( 29937034 )
2018
35
Intraosseous venous structures adjacent to the jugular tubercle associated with an anterior condylar dural arteriovenous fistula. ( 29411060 )
2018
36
Varicocele Due to Post Traumatic Arteriovenous Fistula. ( 29432872 )
2018
37
Dural arteriovenous fistula presenting with acute subdural haematoma showing impending cerebral herniation. ( 29950494 )
2018
38
Isolated intraventricular hemorrhage secondary to dural arteriovenous fistula. ( 29437717 )
2018
39
Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: AA Multicenter Prospective Cohort Study. ( 29398178 )
2018
40
Determinants of patency of arteriovenous fistula in hemodialysis patients. ( 29970738 )
2018
41
Multi-system bleeding risk with a cutaneous angiosarcoma at an arteriovenous fistula site. ( 30250745 )
2018
42
Angiosarcoma of a Thrombosed Arteriovenous Fistula in a Renal Transplant Recipient. ( 30500642 )
2018
43
Angiosarcoma arising within a nonfunctioning arteriovenous fistula. ( 29797521 )
2018
44
Successful endovascular treatment of ruptured bilateral ophthalmic frontal dural arteriovenous fistula. ( 30228839 )
2018
45
Added value of arterial spin-labeling (ASL) and susceptibility weighted-images (SWI) in detecting a mild symptomatic intracranial arteriovenous fistula. ( 30231132 )
2018
46
Percutaneous closure of iatrogenic arteriovenous fistula after pacemaker implantation. ( 30233661 )
2018
47
Renal arteriovenous fistula induced by extracorporeal shock wave lithotripsy treated by retroperitoneoscopic nephrectomy. ( 30239133 )
2018
48
Dural Arteriovenous Fistula Causing Recurrent Transient Global Amnesia. ( 30245773 )
2018
49
Snare technique for endovascular retrieval of coil extending to the atrium after embolization of a dural arteriovenous fistula. ( 30251195 )
2018
50
Microsurgical Management of a Spinal Dural Arteriovenous Fistula With Shared Blood Supply to the Artery of Adamkiewicz: 3-Dimensional Operative Video. ( 30252106 )
2018

Variations for Arteriovenous Fistula

Expression for Arteriovenous Fistula

Search GEO for disease gene expression data for Arteriovenous Fistula.

Pathways for Arteriovenous Fistula

Pathways related to Arteriovenous Fistula according to GeneCards Suite gene sharing:

(show all 18)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.99 HMOX1 IL6 MMP2 RASA1
2 12.34 EPO HMOX1 IL6 MMP2
3
Show member pathways
12.22 IL6 MMP2 RASA1
4 11.49 HMOX1 IL6 MMP2
5 11.38 EPO HMOX1
6 11.37 IL6 MMP2
7
Show member pathways
11.35 IL6 MMP2
8 11.33 EPO HMOX1 IL6
9 11.28 IL6 MMP2
10 11.23 IL6 MMP2
11 11.18 IL6 MMP2
12 11.16 EPO IL6
13 11.14 EPO IL6
14 10.98 HMOX1 IL6
15 10.93 HMOX1 IL6 MMP2
16 10.92 MMP2 RASA1
17 10.65 HMOX1 IL6
18 10.33 HMOX1 IL6 MMP2

GO Terms for Arteriovenous Fistula

Cellular components related to Arteriovenous Fistula according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.02 APOH EPO HMOX1 IL6 MMP2

Biological processes related to Arteriovenous Fistula according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.58 HMOX1 IL6 MMP2
2 ephrin receptor signaling pathway GO:0048013 9.52 MMP2 RASA1
3 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.51 EPO IL6
4 response to estrogen GO:0043627 9.49 EPO HMOX1
5 cellular response to hydrogen peroxide GO:0070301 9.48 IL6 PCNA
6 positive regulation of smooth muscle cell proliferation GO:0048661 9.46 HMOX1 IL6
7 embryo implantation GO:0007566 9.43 EPO MMP2
8 acute-phase response GO:0006953 9.37 EPO IL6
9 response to hypoxia GO:0001666 9.33 EPO HMOX1 MMP2
10 regulation of angiogenesis GO:0045765 9.32 HMOX1 IL6
11 liver regeneration GO:0097421 9.26 HMOX1 PCNA
12 response to dexamethasone GO:0071548 8.96 EPO PCNA
13 negative regulation of myeloid cell apoptotic process GO:0033033 8.62 APOH EPO

Sources for Arteriovenous Fistula

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....